Answers are grounded in this paper and cite their sources.
Cranial cavernous malformations are low-flow vascular lesions that may present with haemorrhage, seizures, or progressive neurological deficits, depending on their location. While many lesions remain clinically silent, symptomatic cavernomas—particularly those located in eloquent regions pose significant management challenges due to their natural history of recurrent bleeding and the potential for accumulating neurological morbidity. Microsurgical resection remains the definitive treatment for selected cases; however, the decision to operate must balance the risks of surgery against the natural course of the disease. Despite advances in microsurgical techniques and peri-operative care, outcomes remain closely linked to lesion location and pre-operative neurological status. This study aims to evaluate surgical outcomes in a contemporary cohort and to identify factors influencing post-operative recovery. We conducted a retrospective analysis of 91 patients undergoing microsurgical resection between the years 2001 and 2023. Outcomes were assessed using the modified Rankin Scale (mRS), with overall and subgroup-based comparisons. A total of 91 patients with cranial cavernous malformations underwent microsurgical treatment. Follow-up was available in 66 patients. The mean follow-up duration was 2.3 years. Favourable outcome (mRS ≤ 2) was observed in 61 patients (92.4%), while 5 patients (7.6%) had an unfavourable outcome. For the overall cohort, the mean mRS improved from 1.65 pre-operatively to 1.27 post-operatively. Microsurgical resection of cranial cavernoma is safe and effective in selected patients. In this descriptive series, baseline preoperative neurological status was strongly linked to final functional recovery.
No takes yet. Share an insight, caveat, or question.
Badarny et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: